Use of inhaler devices and asthma control in severe asthma patients at a referral center in the city of Salvador, Brazil;Manuseio de dispositivos inalatórios e controle da asma em asmáticos graves em um centro de referência em Salvador

Jornal Brasileiro de Pneumologia

Volumn 37, Issue 6, 2011, Pages 720-728

  Coelho, Ana Carla Carvalho ^a   Souza Machado, Adelmir ^a   Leite, Mylene ^a   Almeida, Paula ^b   Castro, Lourdes ^b   Cruz, Constança Sampaio ^c   Stelmach, Rafael ^d   Cruz, Álvaro Augusto ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Bahia State Asthma and Allergic Rhinitis Control Program   (Brazil)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Administration; Asthma; Dry powdered inhalers; Inhalation; Metered dose inhalers

Indexed keywords

EID: 84855854488     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/s1806-37132011000600004     Document Type: Article

References (25)

1. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007.
2. Global Initiative for Asthma-GINA [homepage on the Internet]. Bethesda: National Heart, Lung and Blood Institute. National Institutes of Health, US Department of Health and Human Services [cited 2010 Oct 20]. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. Available from: http://www.ginasthma
3. Ministério da Saúde do Brasil. Departamento de Informática do SUS [homepage on the Internet]. Brasília: DATASUS [cited 2010 Oct 20]. Informações de Saúde. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=02
4. Solé D, Camelo-Nunes IC, Wandalsen GF, Mallozi MC, Naspitz CK; Brazilian ISAAC's Group. Is the prevalence of asthma and related symptoms among Brazilian children related to socioeconomic status? J Asthma. 2008;45(1):19-25.
5. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J. 1996;9(4):636-42.
6. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ. 1993;307(6908): 846-8.
7. Fiterman J, Mattos W, Cukier A, Pizzichini M, Silva RF, Kahan F, et al. Acceptability, preference, tolerance and clinical efficacy of dipropionate beclomethasone delivered by two inhalers in chronic asthma patients: Clenil Pulvinal versus Miflasona Aerolizer. J Bras Pneumol. 2004;30(5):413-8.
8. Souza-Machado C, Souza-Machado A, Franco R, Ponte EV, Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J. 2010;35(3):515-21.
9. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-7.
10. Leite M, Ponte EV, Petroni J, D'Oliveira Júnior A, Pizzichini E, Cruz AA. Evaluation of the asthma control questionnaire validated for use in Brazil. J Bras Pneumol. 2008;34(10):756-63.
11. Muniz JB, Padovani CR, Godoy I. Inalantes no tratamento da asma: avaliação do domínio das técnicas de uso por pacientes, alunos de medicina e médicos residentes. J Pneumol. 2003;29(2):75-81.
12. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16(3):249-54.
13. Molimard M, Le Gros V. Impact of patient-related factor on asthma control. J Asthma. 2008;45(2):109-13.
14. Molimard M. How to achieve good compliance and adherence with inhalation therapy. Curr Med Res Opin. 2005; 21 Suppl 4:S33-7.
15. Santos Pde M, D'Oliveira A Jr, Noblat Lde A, Machado AS, Noblat AC, Cruz AA. Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil. J Bras Pneumol. 2008;34(12):995-1002.
16. Terzano C. Pressurized metered dose inhalers and add-on devices. Pulm Pharmacol Ther. 2001;14(5):351-66.
17. Melani AS, Zanchetta D, Barbato N, Sestini P, Cinti C, Canessa PA, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol. 2004;93(5):439-46.
18. Lenney J, Innes JA, Crompton EK. Inappropriate inhaler use: assessment of use patient preference of seven inhalation devices. EDICI. Respir Med. 2000;94(5):496-500.
19. Khassawneh BY, Al-Ali MK, Alzoubi KH, Batarseh MZ, Al-Safi SA, Sharara AM, et al. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers. Respir Care. 2008;53(3):324-8.
20. Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinetics. 2004;43(6):349-60.
21. Janssens HM, De Jongste JC, Hop WC, Tiddens HA. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest. 2003;123(6):2083-8.
22. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102(4):593-604.
23. Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Respir Med. 2002;96(5):293-304.
24. Ponte EV, Petroni J, Ramos DC, Pimentel L, Freitas DN, Cruz AA. Perception of asthma control in asthma patients. J Bras Pneumol. 2007;33(6):635-40.
25. Araujo AC, Ferraz E, Borges Mde C, Filho JT, Vianna EO. Investigation of factors associated with difficult-to-control asthma. J Bras Pneumol. 2007;33(5):495-501.